Floatz logo

FENTANYL

Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Stanford UniversitySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma cohort.

Asset / SponsorPhaseRating
Mesna
The First Affiliated Hospital with Nanjing Medical University
Phase 3BB
Zofran
Fred Hutchinson Cancer Center
Phase 2B
Benadryl
Stanford University
Phase 2CCC
Ketorolac Tromethamine
Stanford University
Phase 2CCC
HYDROMORPHON
Stanford University
Phase 2CCC
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Stanford University
Phase 2CCC

Same molecule, other indications

FENTANYL is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →